MBX Biosciences (MBX) FY Conference June 09, 2025 10:40 AM ET Speaker0 Good morning. My name is Kent Harlech, and I'm the cofounder and CEO of MBX Biosciences. Speaker1 I would like to thank the Goldman Sachs team for the invitation to participate in this conference and to provide an opportunity to present an update on the company and what is promising to be our most important year in our company's history. With the data released next quarter of our AVAIL Phase II data for the first PTH replacement therapy ...